Arivin Therapeutics, a Helsinki, Finland and Kessel, The Netherlands-based biotech company combating drug-resistant infections, raised €3 million in a seed funding round led by Michiel Seerden Imbestio Capital with participation from private/angel investors, Business Finland, and others.
More on Silicon Canals →

